Can turmeric and grape compounds help slow ALS?

NCT ID NCT04654689

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed Phase 2 trial tested a combination of liposomed curcumin (from turmeric) and resveratrol (from grapes) plus a drug called G04CB02 in 90 people with ALS. The goal was to see if this mix could improve muscle function, thinking, and inflammation over 2 months of treatment. Participants were randomly assigned to get the active treatment or a placebo, and were followed for 4 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
liposomed curcumin and resveratrol plus G04CB02
What this could lead to
If it works, this could point toward a way to slow ALS progression and reduce inflammation.
What could go wrong
This is a small, early-phase trial with only 90 participants. The results may not apply to all ALS patients, and the supplements may not show clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • José Enrique de la Rubia Ortí

    Valencia, Valencia, 46007, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.